Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 31, 2012
[Clinical significance of CD34(+)CD38(+) and CD34(+)CD38(low/-) subgroups in bone marrow of patients with B lymphoblastic leukemia]Le Hao, Yan-Rong Liu, Ya-Zhe Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2014
Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia--rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantationJing Liu, Yu Wang, Lan-Ping Xu, et al.
Leukemia & Lymphoma|February 26, 2013
Cytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapyHong-Hu Zhu, Hao Jiang, Bin Jiang, et al.
Clinical and Experimental Medicine|January 13, 2023
High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic riskNan Xu, Wen-Min Chen, Ling-Di Li, et al.
Annals of Hematology|February 12, 2018
Leukemia-propagating cells demonstrate distinctive gene expression profiles compared with other cell fractions from patients with de novo Philadelphia chromosome-positive ALLHong-Yan Zhao, Yang Song, Xie-Na Cao, et al.
Cancer Letters|February 16, 2025
The expression level of EVI1 and clinical features help to distinguish prognostic heterogeneity in the AML entity with EVI1 overexpressionXiao-Hang Ma, Meng-Ge Gao, Rong-Qi Cheng, et al.
Annals of Hematology|January 5, 2020
Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemiaXiao-Rui Wang, Yan Chang, Xiao-Ying Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5' regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese populationXi Ma, Guorui Ruan, Ying Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 13, 2003
[Follow up Detection of AML/ETO Fushion Transcripts after Chemotherapy or Bone Marrow Transplantation in Leukemia Patients]Ya-Zhen Qin, Yan-Rong Liu, Jin-Lan Li, et al.
Leukemia Research|November 23, 2016
PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapyYan-Huan Zhang, Ai-Dong Lu, Lu Yang, et al.
Pageof 17